HomeOrganizations › TRANSCELERATE BIOPHARMA INC

TRANSCELERATE BIOPHARMA INC

PA · Medical Research · EIN 460886344

11
Executives Disclosed
$38.6M
Annual Revenue
$55.3M
Total Assets
5.6:1
Internal Pay Ratio

TRANSCELERATE BIOPHARMA INC has 11 executives with disclosed compensation. The highest-paid executive, Dalvir Gill (FORMER CEO), received peak total compensation of $2,698,291. The sector average for Medical Research executives is $311K.


Top Executive Compensation Over Time


Executive Compensation

Name Title Peak Comp. Latest Comp. Years vs. Household
Dalvir Gill FORMER CEO $2.7M $2.5M 2016–2023 36x
Janice Chang CEO $1.1M $1.1M 2016–2024 14.7x
Allison Cuff Shimooka COO $636K $636K 2023–2024 8.5x
Jennifer A Burgess VP, GLOBAL COMMUNICATIONS & ENGAGEMENT $614K $506K 2016–2024 8.2x
Cara L Rinaldi VP, PORTFOLIO MANAGEMENT $575K $471K 2016–2024 7.7x
Anthony Garges HEAD OF FINANCE & ADMINISTRATION $535K $445K 2016–2024 7.1x
Jeneen Donadeo EXEC. PORTFOLIO DIRECTOR $519K $430K 2017–2024 6.9x
Robert Dicicco VP, PORTFOLIO MANAGEMENT $456K $456K 2022–2024 6.1x
Patrice Wright HEALTH AUTHORITY ENGAGEMENT DIRECTOR $288K $288K 2020–2021 3.8x
Denise Reyes DIRECTOR, VALUE & IMPLEMENTATION $241K $241K 2017–2019 3.2x
Sarah L Plush DIRECTOR OF OPERATIONS $172K $172K 2016–2016 2.3x

Annual Summary

Year Executives Avg. Comp. Highest Comp. Total Payroll
2016 6 $490K $1.6M $2.9M
2017 7 $478K $1.7M $3.3M
2018 7 $521K $1.7M $3.6M
2019 7 $565K $1.8M $4.0M
2020 7 $616K $1.9M $4.3M
2021 7 $660K $2.0M $4.6M
2022 7 $823K $2.7M $5.8M
2023 8 $829K $2.5M $6.6M
2024 7 $578K $1.1M $4.0M
Email Alerts

Get notified about TRANSCELERATE BIOPHARMA INC

Get an email when a new IRS Form 990 filing is posted that includes this organization. We send a confirmation link first - we don't add you to any other list.